Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A

L. Quadro, L. Panariello, D. Salvatore, F. Carlomagno, M. Del Prete, V. Nunziata, V. Colantuoni, G. Di Giovanni, M. L. Brandi, M. Mannelli, R. Gheri, U. Verga, A. Libroia, N. Berger, A. Fusco, M. Grieco, M. Santoro

Research output: Contribution to journalArticlepeer-review


The occurrence of mutations in the RET protooncogene has been investigated in 12 multiple endocrine neoplasia type 2A families and 18 cases of sporadic thyroid medullary carcinomas and pheochromocytomas. Ten of 12 families showed single base substitutions in the RET protooncogene exons 10 and 11, coding for the extracellular domain of the protein. Tumor tissues from 2 multiple endocrine neoplasia type 2A patients were analyzed at the DNA and ribonucleic acid levels and revealed the same heterozygous mutations found in the peripheral blood lymphocytes. This demonstrates that both the normal and mutant alleles are expressed. No mutations in these exons were detected in the 18 cases of sporadic tumors investigated. These data provide further evidence that the mutated RET protooncogene acts in a dominant fashion and is responsible for the pathogenesis of this syndrome.

Original languageEnglish
Pages (from-to)590-594
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Issue number2
Publication statusPublished - Aug 1994

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A'. Together they form a unique fingerprint.

Cite this